Assessment report
AVB Atrioventricular Block BAFF B cell-Activating Factor BCRP Breast Cancer Resistance Protein BID Bis In Die: twice a day BP Blood Pressure B/R Benefit / Risk BW Body Weight cAMP Cyclin Adenosine Monophosphate CBC Complete Blood Count CDA Confirmed Disability Accumulation CFA Complete Freund’s Adjuvant CFU Colony-Forming Unit
Download Assessment report
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Qucs - A Tutorial
qucs.sourceforge.netgiven circuit in g.8the ground symbol is placed at the negative terminal of the ... You choose the \DC simulation" block which can be found in the Components tab in the simulations category. 8. Figure 8: Ground symbol as well as DC simulation in place Labelling wires If you want the voltage between the two resistors (the divided voltage) be ...
ComEx Control Stations - BARTEC
www.bartec.deE Switching or illuminating module or terminal block FF 00 – without accessory 01 – protective metal shroud 02 – external earth connection 03 – shroud + external earth connection 10 – labelling by template 18 – locking device 33 – earth plate 99 – on request Selection Key ComEx Control Station 0 7 - 3 5 * A E * - * * * B C D * D ...
MiCOM P220/P225
www.se.comProtective Conductor (Earth) Terminal if that terminal is part of a terminal block or sub-assembly e.g. power supply. *NOTE: THE TERM EARTH USED THROUGHOUT THIS GUIDE IS THE DIRECT EQUIVALENT OF THE NORTH AMERICAN TERM GROUND. 3.2 Labels . See Safety Guide (SFTY/4L M/G11) for equipment labelling information. 4. INSTALLING, …